Persistent cough in asthma patients study

未提供0 个研究点目标入组 500 人开始时间: 待定

适应症

试验速览

暂无简介。

•A diagnosis of asthma is recorded in the DigiKar EMR data.
•Male or female sex and aged 18 years or older (assessed using the DigiKar EMR data).
•Prescription records for ICS/LABA/LAMA are available in DigiKar EMR data for at least 4 consecutive weeks immediately preceding the data extraction.
•Electronic signed and dated informed consent is provided.
•The patient is willing and able to complete the web-based survey.
•Scores on the Morisky Medication Adherence Scale-8 (MMAS-8) are >-6; this instrument will be administered as part of the web survey.

•Current smoker or former smoker with a total lifetime smoking history of 10 years or more at the time of the web-based survey (assessed by self-reporting in the survey).
•A confirmed diagnosis in DigiKar EMR data of another chronic respiratory disease known to be a primary cause of cough within 12 months before distribution of the web-based survey.
•Presence of prescription records in DigiKar EMR data for six or more short-acting B2-agonist (SABA) inhalers within 12 months before distribution of the web-based survey.
•Presence of a prescription record in DigiKar EMR data for an angiotensin-converting enzyme (ACE) inhibitor within 12 months before distribution of the web-based survey.
•Presence of a prescription record in DigiKar EMR data for an asthma-related biological therapy within 12 weeks before distribution of the web-based survey.
•Current participation in any interventional clinical study within 12 months before the web-based survey (assessed by self-reporting in the web-based survey).

发起方

未提供